Biologics for asthma and COPD
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study looks at how well medicines called biologics work for people with asthma or COPD. Biologics are special shots that target certain parts of the immune system to reduce inflammation. Researchers want to see if these treatments can help control symptoms and prevent flare-ups.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a confirmed diagnosis of asthma or COPD.
- Your asthma must not be well-controlled with standard treatments, or your COPD must cause frequent flare-ups despite triple therapy.
- Your doctor has decided to start or switch to a biologic medicine (like omalizumab, mepolizumab, benralizumab, dupilumab, tezepelumab, or depemokimab) for your condition.
- You must be able to attend follow-up visits for at least 12 months.
- You cannot be pregnant, breastfeeding, or planning pregnancy during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how biologic medicines (special injections or infusions) are used to treat severe asthma in Hong Kong. It may help researchers understand why some people stop or switch these treatments.
This study tests a medication called mepolizumab (given as an injection) in people with COPD who have high eosinophils and frequent flare-ups. The goal is to see if it reduces inflammation and helps them breathe better, by looking at airway changes with special scans.
This study tests a new way to monitor severe asthma that is driven by high levels of inflammation (T2-high). It involves a bronchoscopy (a thin tube to look inside your lungs) to see how well the treatment is working.
This study looks at how the immune system works and how well diseases like asthma, COPD, and others are controlled. You may join if you have one of these conditions or if you are a healthy volunteer or smoker without lung disease.
This study looks at how well different biologic treatments work for people with severe or mild-to-moderate asthma, and compares them to healthy volunteers. It aims to find which treatments work best for different asthma types.
This study tests if biologic drugs are safe and effective for people with allergic bronchopulmonary aspergillosis (ABPA) who also have severe asthma. It may help if you've had an asthma attack in the past year.
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.